Document is current
Any future updates will be listed below
-
Authors
De Toni, Flavia https://orcid.org/0000-0001-6701-7710
Ragaglia, Vanessa https://orcid.org/0009-0007-3202-5447
Schecter, Devin
Miller, Angela S.
Gonzalez, Eric
Wagner, Erik J.
Xu, Xin https://orcid.org/0000-0003-1163-9304
Payne, R. Mark https://orcid.org/0000-0002-6232-3628
Mess, Jean-Nicholas https://orcid.org/0009-0002-8756-3828
Baile, Matthew G. https://orcid.org/0000-0002-2680-1178
Clements-Egan, Adrienne
Shankar, Gopi https://orcid.org/0009-0002-7224-1201
- License Information
-
More Information
Article History
Received: 12 April 2025
Accepted: 25 May 2025
First Online: 25 June 2025
Declarations
:
: FDT, VR, MGB, ACE, and GS are employed by Larimar Therapeutics, Inc. (“Larimar”) and they and/or their immediate family members may hold company stock or stock options. ASM (Johnson & Johnson Innovative Medicine, Spring House, PA, USA) and DS (Instadiagnostics, Philadelphia, PA, USA) were employees of Larimar at the time this work was conducted. RMP is a paid consultant to Larimar and owns stock in this company. GS chairs the Larimar Scientific Advisory Board. EG, EJW, and XX declare no conflict of interest.
